A biosimilar is designed to match the reference product--to be as close to the reference as the reference is to itself considering batch-to-batch variability and manufacturing changes over its lifetime. Interchangeability will require additional data, however, the interchangeable biologic itself will be the same as that approved for biosimilarity.
No takes yet. Share an insight, caveat, or question.
McCamish et al. (2015) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: